Cancer genetics expert Dr. Kelly Bolton appointed

Waltham, MA, July 25, 2022 (GLOBE NEWSWIRE) — good cella Harvard Stem Cell Institute company, today appointed Kelly Bolton MD, Ph.D., M.Phil., to its Scientific Advisory Board.

With a background in medical oncology and genetic epidemiology, Dr. Bolton focused her research on the interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis.

“GoodCell’s research in the area of ​​acquired genetics is of particular interest to me,” said Dr. Bolton. “I look forward to advising the company on the development of powerful diagnostics to help its Personal Biobanking members identify acquired genetic alterations and their impact on their long-term health.”

dr Bolton received her medical degree from the David Geffen School of Medicine at UCLA and her Ph.D. in Genetic Epidemiology from the University of Cambridge. She is an assistant professor in the medical school at Washington University Medical School in St. Louis, Missouri, vice president of the Cambridge University Public Health and Epidemiology Society, and president of the Cambridge University Public Health and Epidemiology Society. dr Bolton is a recipient of the Evans MDS Young Investigator Award, Leukemia and Lymphoma Society Fellows Award, ASH Research Training Program Fellowship, Marilyn Bersch Medical Scientist Training Program Fellowship, and American Society of Human Genetics Trainee Research Semifinalist.

“We are honored that Dr. Bolton joins our valued team of advisors,” said Chris Garcia, GoodCell’s Chief Executive Officer. “Your research and experience in oncology and genetics are critical as we work to expand our products and services to our Personal Biobanking members.”

To learn more about GoodCell and how to become a member, please visit www.GoodCell.com.

About GoodCell

GoodCell is a life sciences company providing proactive, preventative healthcare services that enable members to…